Rowett Institute of Nutrition & Health, University of Aberdeen, Bucksburn, Aberdeen, United Kingdom.
Mol Nutr Food Res. 2012 Jul;56(7):1148-59. doi: 10.1002/mnfr.201100763. Epub 2012 May 30.
The dietary fatty acid cis9,trans11 conjugated linoleic acid (cis9,trans11 CLA) has been shown to modify the function of endothelial cells, monocytes, and platelets, all of which are involved in the development of atherosclerosis. Potential mechanisms for the platelet effects have not been assessed previously. In this study, we assessed how supplementation of the diet with an 80:20 cis9,trans11 CLA blend affects the platelet proteome.
In a double-blind, randomized, placebo-controlled, parallel-group trial, 40 overweight but apparently healthy adults received either 4 g per day of cis9,trans11 CLA-enriched oil or placebo oil, consisting of palm oil and soybean oil, for 3 months. Total platelet proteins were extracted from washed platelets, separated using two-dimensional gel electrophoresis and differentially regulated protein spots were identified by LC-ESI-MS/MS. Supplementation with the CLA blend, compared with placebo, resulted in significant alterations in levels of 46 spots (p < 0.05), of which 40 were identified. Network analysis revealed that the majority of these proteins participate in regulation of the cytoskeleton and platelet structure, as well as receptor action, signaling, and focal adhesion.
The platelet proteomics approach revealed novel insights into regulation of cellular biomarkers of atherogenic and thrombotic pathways by an 80:20 cis9,trans11 CLA blend.
饮食中的脂肪酸反式 9,顺式 11 共轭亚油酸(cis9,trans11CLA)已被证明能改变内皮细胞、单核细胞和血小板的功能,而这些细胞均参与动脉粥样硬化的形成。以前尚未评估过血小板作用的潜在机制。在这项研究中,我们评估了饮食中补充 80:20cis9,trans11CLA 混合物如何影响血小板蛋白质组。
在一项双盲、随机、安慰剂对照、平行组试验中,40 名超重但看似健康的成年人每天接受 4 克 cis9,trans11CLA 丰富的油或安慰剂油(由棕榈油和豆油组成),持续 3 个月。从洗涤后的血小板中提取总血小板蛋白,使用二维凝胶电泳分离,并通过 LC-ESI-MS/MS 鉴定差异调节的蛋白质斑点。与安慰剂相比,CLA 混合物的补充导致 46 个斑点(p <0.05)的水平发生显著变化,其中 40 个被鉴定。网络分析表明,这些蛋白质中的大多数参与调节动脉粥样硬化和血栓形成途径的细胞生物标志物的细胞骨架和血小板结构,以及受体作用、信号转导和焦点粘附。
血小板蛋白质组学方法揭示了 80:20cis9,trans11CLA 混合物对动脉粥样硬化和血栓形成途径的细胞生物标志物的调节的新见解。